Table 2.

Total number of positive tests for SARS-CoV-2 IgM/IgG with relative percentage and 95% Confidence Interval by round of survey as well as by Governorate, age-group, gender and presence of symptoms.

	First survey		Second survey		Third survey
Area	Positive tests	Percentage (95% CI)	Positive tests	Percentage (95% CI)	Positive tests	Percentage (95% CI)
Amman	6	0.3 (0.2–0.4)	168	8.2 (7.9–8.4)	817	38.0 (37.5–38.5)
Ajloon	0	0	1	1.2 (1.1–1.3)	42	41.2 (40.6–41.8)
Aqaba	0	0	4	4.5 (4.3–4.7)	38	36.5 (36.1–36.9)
Balka	2	0.8 (0.6–0.9)	32	8.4 (8.2–8.6)	69	27.1 (26.7–27.5)
Irbid	4	0.4 (0.3–0.5)	18	2.1 (1.9–2.2)	342	35.4 (35.0–35.9)
Jarash	1	0.9 (0.7–1.1)	3	3.2 (3.0–3.3)	42	28.6 (28.2–29.0)
Karak	0	0	27	17.3 (17.0–17.5)	80	45.7 (45.1–46.3)
Ma'an	0	0	20	35.1 (34.7–35.4)	32	53.3 (52.5–54.1)
Madaba	0	0	0	0.0	21	18.6 (18.4–18.9)
Mafraq	0	0	6	2.1 (1.9–2.2)	49	17.2 (16.9–17.4)
Tafila	0	0	0	0.0	24	44.4 (44.0–44.9)
Zarqa	0	0	69	8.6 (8.4–8.8)	167	26.3 (25.9–26.6)
Age-group
<5		0.0	13	5.2 (5.0–5.4)	32	29.1 (28.8–29.3)
5–9	2	0.4 (0.3–0.5)	34	8.8 (8.5–9.0)	126	38.0 (37.6–38.3)
10–14		0.0	41	6.9 (6.7–7.1)	179	36.3 (36.0–36.6)
15–19	1	0.2 (0.1–0.3)	42	9.6 (9.4–9.9)	201	36.5 (36.1–36.9)
20–29	2	0.4 (0.3–0.5)	50	7.1 (6.9–7.3)	283	31.4 (31.3–31.7)
30–59	6	0.4 (0.3–0.5)	152	6.7 (6.6–6.8)	740	34.8 (34.3–35.2)
60–64	2	0.8 (0.7–1.0)	7	4.5 (4.4–4.6)	91	39.1 (38.6–39.6)
65+		0.0	9	4.4 (4.3–4.5)	71	30.0 (29.5–30.4)
Gender
Male	5	0.2 (0.1–0.3)	121	5.5 (5.4–5.7)	723	31.9 (31.6–32.5)
Female	8	0.3 (0.2–0.4)	227	8.1 (7.9–8.3)	1000	37.5 (37.1–38.0)
Infection type
Symptomatic	2	0.1 (0.1–0.2)	114	2.3 (2.2–2.4)	652	45.1 (44.6–45.7)
Asymptomatic	11	0.2 (0.1–0.2)	234	4.7 (4.6–4.8)	1071	29.8 (29.4–30.2)
Total	13	0.3 (0.2–0.4)	348	7.0 (6.8–7.2)	1723	34.2 (33.8–34.6)